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Purpose
Previous studies demonstrated that electroacupuncture
(EA) alleviates hyperalgesia, but the mechanisms
remained unclear. Because it is well known that inter-
leukin-17 (IL-17) is associated with autoimmune disor-
ders, the present study was designed to determine
whether spinal IL-17 plays a role in inflammatory pain
and, if so, whether EA inhibits spinal IL-17 expression
during such pain.
Methods
Hyperalgesia was induced by injecting complete
Freund’s adjuvant (CFA, 0.08 ml, 40 μg Mycobacterium
tuberculosis) into one hind paw of each rat. EA treat-
ment, 10 Hz at 3 mA, was given at acupoint GB30 twice
for 20 min each, once immediately post-CFA and again
2 hours later. Paw withdrawal latency (PWL) was tested
before (-48 h) and 2 and 24 hours after CFA to assess
behavioral hyperalgesia. IL-17 antibody (0.2-2 µg/rat)
was given intrathecally (i.t.) 24 h before CFA to block
the action of basal IL-17 and 2 hours prior to each of
two PWL tests to block CFA-induced IL-17. I.t. recom-
binant IL-17 (10-400 ng/rat) was administered to naive
rats to determine its effects on PWL and phosphoryla-
tion of NR1 (p-NR1). P-NR1 is known to modulate N-
methyl-D-aspartate receptor (NMDAR) activity and to
facilitate pain. Spinal cords were removed for immunos-
taining of IL-17, double immunostaining of IL-17/cell
markers and IL-17 receptor subtype A (IL-17RA)/NR1,
and western blot to measure p-NR1 and IL-17RA.
Results
The data showed that (1) IL-17 is selectively up-regu-
lated in astrocytes, 2) IL-17RA is localized and up-regu-
lated in NR1-immunoreactive neurons, and 3) an IL-17
antibody at 2 µg/rat significantly increased PWL
(p<0.05) and decreased p-NR1 and IL-17RA in CFA-
and IL-17-injected rats compared to control. EA signifi-
cantly inhibited hyperalgesia, IL-17, IL-17RA, and p-
NR1.
Conclusion
The results suggest that (1) spinal IL-17 is produced by
astrocytes and enhances p-NR1 to facilitate inflamma-
tory pain, and 2) EA inhibits hyperalgesia by suppressing
IL-17.
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